Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $26.9 million.

  • Lemaitre Vascular's Accumulated Expenses rose 1464.27% to $26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.9 million, marking a year-over-year increase of 1464.27%. This contributed to the annual value of $24.7 million for FY2024, which is 457.51% up from last year.
  • According to the latest figures from Q3 2025, Lemaitre Vascular's Accumulated Expenses is $26.9 million, which was up 1464.27% from $23.0 million recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Accumulated Expenses high stood at $26.9 million for Q3 2025, and its period low was $12.9 million during Q1 2022.
  • Moreover, its 5-year median value for Accumulated Expenses was $19.9 million (2025), whereas its average is $19.5 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 1007.31% in 2022, then soared by 3639.88% in 2023.
  • Lemaitre Vascular's Accumulated Expenses (Quarter) stood at $16.3 million in 2021, then increased by 22.26% to $20.0 million in 2022, then increased by 18.45% to $23.6 million in 2023, then increased by 4.58% to $24.7 million in 2024, then rose by 8.9% to $26.9 million in 2025.
  • Its Accumulated Expenses was $26.9 million in Q3 2025, compared to $23.0 million in Q2 2025 and $19.9 million in Q1 2025.